NHS Introduces Amivantamab as a New Treatment Option for Advanced Lung Cancer Patients
## Amivantamab to Provide New Treatment Option for Cancer Patients on the NHS
Patients diagnosed with a specific type of lung cancer may gain access to a new treatment option through the NHS. The new drug, Amivantamab, is expected to be offered to those with advanced lung cancer.
According to NICE, "Just over 1,100 people with a form of advanced lung cancer are set to benefit from a new first-line treatment option today." This means hundreds of patients in Britain will have this better treatment available starting now.
The introduction of Amivantamab marks an important step in lung cancer treatment, providing hope for patients and their families. As the NHS expands its treatment options, many will see improvements in their care and health outcomes.
This article is for general information only and is not a substitute for professional medical advice. Always speak to a GP or qualified health professional about your own health.